+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 65Years
All Genders
ID06278532

Study to Validate Lithuanian Versions of Key Schizophrenia Symptom and Cognition Scales

Led by Lithuanian University of Health Sciences · Updated on 2024-02-26

200

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to validate the Lithuanian versions of three diagnostic tools the Brief Negative Symptoms Scale, the Calgary Depression Scale for Schizophrenia, and the Schizophrenia Cognition Rating Scale. These tools assess negative symptoms, depressive symptoms, and cognitive deficits in people with schizophrenia. The study compares these results with established scales including the Positive and Negative Symptoms Scale, Montgomery Asberg Depression Rating Scale, and Montreal Cognitive Assessment to ensure accuracy and relevance in a Lithuanian sample. The study involves using the Lithuanian versions of these three scales, which are semi-structured interviews with multiple items assessing specific symptoms of schizophrenia. The Brief Negative Symptoms Scale focuses on negative symptoms, the Calgary Depression Scale evaluates depressive symptoms in schizophrenia patients, and the Schizophrenia Cognition Rating Scale assesses cognitive deficits. Participants will be evaluated using these scales alongside other established assessments for comparison. Participants will undergo evaluations using several symptom and cognition assessment tools during a single study visit Day 1. Researchers will analyze correlations between negative symptoms, depressive symptoms, cognitive deficits, and health-related quality of life. The primary outcome is the validation of the Lithuanian versions of the three scales. The study is observational, with no treatment intervention, and participants are involved in diagnostic interviews and standard assessments during their participation.

CONDITIONS

Brief Title

Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS

Research Team

J

Jonas Montvidas, MD

A

Algirdas Musneckis, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here